Article info
Ovarian Cancer
Phase II Study of Docetaxel Weekly in Combination With Carboplatin Every 3 Weeks as First-Line Chemotherapy in Stage IIB to Stage IV Epithelial Ovarian Cancer
- Address correspondence and reprint requests to Bengt Sorbe, MD, PhD, Department of Gynecological Oncology, University Hospital, SE-701 85 Örebro, Sweden. E-mail: bengt.sorbe{at}orebroll.se.
Citation
Phase II Study of Docetaxel Weekly in Combination With Carboplatin Every 3 Weeks as First-Line Chemotherapy in Stage IIB to Stage IV Epithelial Ovarian Cancer
Publication history
- Received April 27, 2011
- Accepted August 29, 2011
- First published January 1, 2012.
Online issue publication
June 17, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2012 by IGCS and ESGO